Huahai Pharmaceuticals: is actively working with Pfizer to accelerate the localization of Paxlovid to ensure adequate supply of Paxlovid in the Chinese market
Read Time:15 Second
Huahai Pharmaceutical said in an interactive platform on January 10, the company is actively cooperating with Pfizer to accelerate the work of the localization project of Paxlovid to ensure adequate supply of Paxlovid in the Chinese market and continue to meet the demand of Chinese patients for new crown treatments.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
Average Rating